Abbott Laboratories (ABT) Shares Sold by Perkins Investment Management LLC

Lloyd Doyle
January 13, 2018

Heat Biologics, Inc. has 1 buy ratings, 0 holds and 0 sells even after the stock tumbled -67.2% from its high of $1.25 to a $14.88 million market value through last close. The Tompkins Financial Corp holds 24,452 shares with $1.30M value, up from 4,148 last quarter. Cedar Hill Associates Llc who had been investing in Abbott Labs for a number of months, seems to be bullish on the $102.52B market cap company. The lowest price the stock reached in the last trading day was $0.405 and compares with the $0.30 52-week low. This is an increase of 4,299% compared to the average daily volume of 2,618 call options.

News headlines about Abbott Laboratories (NYSE:ABT) have trended somewhat positive on Thursday, Accern reports. It has underperformed by 21.19% the S&P500. Finally, RBC Capital Markets reduced their price target on shares of Abbott Laboratories from $48.00 to $46.00 and set an "outperform" rating on the stock in a report on Thursday, January 26th. Mogy Joel R Investment Counsel Inc who had been investing in Equinix Inc for a number of months, seems to be bullish on the $34.11B market cap company.

The stock increased 0.80% or $0.85 during the last trading session, reaching $106.79. Abbott Laboratories has had 20 insider trades in the last 3 months, including 1 open market buys and 19 sells. (NYSE:AWK) has risen 3.35% since January 12, 2017 and is uptrending. Finally, Sather Financial Group Inc bought a new position in shares of Abbott Laboratories during the 2nd quarter worth approximately $292,000. The business's revenue for the quarter was up 2.8% on a year-over-year basis.

Since August 8, 2017, it had 2 insider buys, and 1 insider sale for $4.48 million activity. (NASDAQ:REIT) on Monday, August 7. 24,693 shares were sold by Comstock Elizabeth J, worth $633,375. Shares for $98,323 were sold by Bracken Sharon J.

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 91% are positive. Cowen & Co maintained it with "Buy" rating and $55.0 target in Friday, September 22 report. As per Thursday, September 28, the company rating was maintained by Wells Fargo. The company was downgraded on Friday, February 3 by PiperJaffray. Of those analysts, 16 rate stock as a Strong Buy, 3 rate it as Hold, and just no analyst rates it as a Moderate Sell. Robert W. Baird maintained American Water Works Company, Inc. The rating was downgraded by Miller Tabak on Wednesday, October 11 to "Sell". The company has 1 year Price Target of $63.67. TheStreet upgraded the shares of GE in report on Tuesday, July 21 to "Buy" rating. RBC Capital Markets maintained it with "Outperform" rating and $310 target in Tuesday, July 28 report.


Investors sentiment decreased to 1.23 in 2017 Q3. Its up 0.05, from 1 in 2017Q2. 46 funds opened positions while 186 raised stakes. Peak6 Invests Limited Partnership stated it has 85,867 shares. Green Valley Investors Limited Com invested in 2.11 million shares or 5.5% of the stock. Kcm Investment holds 0.95% or 640,326 shares. (NYSE:CAH). Barrow Hanley Mewhinney Strauss Ltd Liability Corporation reported 20.05 million shares. Stephens Inc Ar invested 0.03% of its portfolio in American Water Works Company, Inc. (NASDAQ:REIT) for 155 shares. Hap Trading Limited Liability Co reported 11,036 shares or 0.01% of all its holdings. Guyasuta Advsrs invested in 217,584 shares or 0.63% of the stock. First Merchants Corp has 84,576 shares for 0.78% of their portfolio. Tarbox Family Office holds 0.01% in Cardinal Health, Inc. Lee Danner And Bass Inc stated it has 59,852 shares or 0.34% of all its holdings. Massachusetts Financial Co Ma, a Massachusetts-based fund reported 49.17 million shares. Colorado-based Rocky Mountain Advisers Limited Liability Company has invested 0.11% in General Electric Company (NYSE:GE). Abbott Laboratories earned a news sentiment score of 0.11 on Accern's scale. It turned negative, as 47 investors sold ABT shares while 563 reduced holdings.

Other hedge funds also recently added to or reduced their stakes in the company. The investment professionals in our partner's database now own: 1.21 billion shares, down from 1.22 billion shares in 2017Q2. 401.33 million shares or 2.97% more from 389.74 million shares in 2017Q2 were reported. The stock of Abbott Laboratories (NYSE:ABT) has "Buy" rating given on Friday, September 22 by Stifel Nicolaus. Co Bank & Trust accumulated 424,859 shares. Peoples Services Corporation has invested 0.67% in Abbott Laboratories (NYSE:ABT). During the same quarter in the previous year, the business posted $0.59 EPS. equities research analysts forecast that Abbott Laboratories will post 2.5 earnings per share for the current year. Covington Investment Advisors Inc invested in 1.06% or 54,211 shares. Fincl Capital Mgmt Limited holds 5,930 shares or 0.06% of its portfolio. Heritage Wealth Advisors reported 4,117 shares stake. Capital Research Global Investors raised its stake in shares of Abbott Laboratories by 45.7% during the second quarter.

Abbott Laboratories (ABT) surprised the stock market in its last reported earnings when it earned $0.66 a piece versus the consensus-estimated $0.65. Da Davidson And Communications reported 162,785 shares stake. Bank of America downgraded the shares of AWK in report on Wednesday, July 6 to "Neutral" rating. BMO Capital Markets restated a "market perform" rating on shares of Abbott Laboratories in a research note on Thursday, October 19th. Mutual Of Omaha Financial Bank Wealth Mgmt accumulated 121,293 shares or 2.34% of the stock. Moreover, Liberty Capital has 0.57% invested in Abbott Laboratories (NYSE:ABT). Stockholders of record on Friday, January 12th will be issued a $0.28 dividend. Abbott Laboratories's dividend payout ratio is presently 87.60%.

Since August 1, 2017, it had 0 buys, and 6 sales for $22.86 million activity. Td Asset Mgmt reported 0.12% in Abbott Laboratories (NYSE:ABT).

Other reports by Iphone Fresh

Discuss This Article

FOLLOW OUR NEWSPAPER